Cohen H, Scott SD, Mackie IJ, et al. The development of hypoprothrombinaemia following antibiotic therapy in malnourished patients with low serum vitamin K
1
levels.
Br J Haematol
68: 63 - 66, 1988.
Conly J and Stein K. Reduction of vitamin K
2
concentrations in human liver associated with the use of broad spectrum antimicrobials.
Clin Invest Med
17: 531 - 539, 1994.
Shearer MJ, Bechtold H, Andrassy K, et al. Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status.
J Clin Pharmacol
28: 88 - 95, 1988.
Goss TF, Walawander CA, Grasela TH, et al. Prospective evaluation of risk factors for antibiotic-associated bleeding in critically ill patients.
Pharmacotherapy
12: 283 - 291, 1992.
Fuller R. Probiotics in human medicine.
Gut
32: 439 - 442, 1991.
Elmer GW, Surawicz CM, and McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections.
JAMA
275: 870 - 876, 1996.
Catanzaro JA and Green L. Microbial ecology and probiotics in human medicine (Part II).
Alt Med Rev
2: 296 - 305, 1997.
Gorbach SL. Lactic acid bacteria and human health.
Ann Med
22: 37 - 41, 1990.
Gotz V, Romankiewicz JA, Moss J, and Murray HW. Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation.
Am J Hosp Pharm
36: 754 - 757, 1979.
Colombel JF, et al. Yoghurt with
Bifidobacterium longum
reduces erythromycin-induced gastrointestinal effects.
Lancet
2(8549): 43, 1987.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.
